Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues and adjusted earnings for the second quarter of fiscal 2026.
MDT Earnings: Medtronic Q2 FY26 revenue and adj. profit beat estimates
Categories
Medical Devices
Earnings Summary: Highlights of Boston Scientific’s Q3 2025 results
Medical device maker Boston Scientific Corporation (NYSE: BSX) on Wednesday reported financial results for the third quarter of 2025. The company also issued
Intuitive Surgical (ISRG) Q3 FY25 revenue and earnings beat estimates
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) on Wednesday reported stronger-than-expected revenue and earnings for the third quarter of fiscal 2025.
Abbott Laboratories Q3 adj. earnings rise on higher sales; meet Street view
Abbott Laboratories (NYSE: ABT) reported higher sales and adjusted earnings for the third quarter of fiscal 2025. The healthcare company also reaffirmed
Earnings Summary: AngioDynamics (ANGO) reports Q1 loss; sales up 12.2%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Thursday reported a net loss for the first quarter of 2026. Revenues increased 12.2%
Earnings Summary: A snapshot of CooperCompanies’ (COO) Q3 2025 report
Medical device maker CooperCompanies (NYSE: COO) has reported a double-digit increase in adjusted earnings for the third quarter of 2025 amid strong
IPO News: Picard Medical files for US IPO amid growth push
After a modest start to the year, IPO activity gained momentum in the second quarter, despite lingering macro headwinds and policy uncertainty.
MDT Earnings: Medtronic Q1 2026 adj. profit rises on higher sales
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in net sales and adjusted earnings for the first quarter
Earnings Summary: Revvity (RVTY) reports higher Q2 2025 revenues
Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenues for the second
Earnings: A snapshot of Thermo Fisher Scientific’s (TMO) Q2 2025 report
Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in life sciences, on Wednesday announced financial results for the second quarter of
Abbott Laboratories (ABT) Q2 2025 sales and earnings beat estimates
Abbott Laboratories (NYSE: ABT) on Thursday announced financial results for the second quarter of fiscal 2025, reporting an increase in sales and
Johnson & Johnson to report Q2 earnings on July 16. Here’s what to expect
Johnson & Johnson's (NYSE: JNJ) business strategy for fiscal 2025 is focused on reducing the impact of patent expirations on its revenue.
Earnings Summary: CooperCompanies (COO) reports higher Q2 revenue and profit
Medical device maker CooperCompanies (NYSE: COO) has reported an increase in adjusted earnings for the second quarter of 2025, aided by a
MDT Earnings: A snapshot of Medtronic’s Q4 2025 report
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues for the fourth quarter of 2025, which translated into a
Earnings Summary: Revvity (RVTY) reports higher revenue and earnings for Q1 2025
Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenue and adjusted profit
Earnings: Intuitive Surgical (ISRG) reports higher revenue and profit for Q1 2025
Healthcare technology company Intuitive Surgical Inc. (NASDAQ: ISRG) Wednesday reported a sharp increase in revenue and adjusted earnings for the first quarter
Earnings: Highlights of Thermo Fisher Scientific’s (TMO) Q1 2025 report
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced financial results for the first quarter of 2025, reporting a modest increase in
AngioDynamics (ANGO) Q3 2025 loss narrows; sales down 4%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues decreased by
Earnings Summary: Highlights of CooperCompanies (COO) Q1 2025 results
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the first quarter of 2025, reporting an increase in revenues and
MDT Earnings: Medtronic reports higher Q3 2025 revenue and adj. profit
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in revenues and adjusted profit for the third quarter of
Earnings Summary: Highlights of IDEXX’s Q4 2024 report
Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and net income for the fourth quarter of 2024.